The US Leads The World In The Weight-Loss Injection Boom
The US Leads The World In The Weight-Loss Injection Boom Novo Nordisk’s obesity-drug franchise has surged at a remarkable pace. In just four years, revenue from its weight-management treatments ballooned roughly tenfold – from about $1.3 billion in 2021 to approximately $12.4 billion in 2025. The growth has been fueled largely by Wegovy, the company’s […]
The US Leads The World In The Weight-Loss Injection Boom Read More »







